- Home
- KIO vs PSNL Comparison
KIO vs PSNL Comparison
Compare KIO & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIO
- PSNL
- Stock Information
- Founded
- KIO 2011
- PSNL 2011
- Country
- KIO United States
- PSNL United States
- Employees
- KIO 2400
- PSNL N/A
- Industry
- KIO Investment Managers
- PSNL Medical Specialities
- Sector
- KIO Finance
- PSNL Health Care
- Exchange
- KIO Nasdaq
- PSNL Nasdaq
- Market Cap
- KIO 522.7M
- PSNL 484.0M
- IPO Year
- KIO N/A
- PSNL 2019
- Fundamental
- Price
- KIO $12.46
- PSNL $4.72
- Analyst Decision
- KIO
- PSNL Strong Buy
- Analyst Count
- KIO 0
- PSNL 4
- Target Price
- KIO N/A
- PSNL $8.13
- AVG Volume (30 Days)
- KIO 136.5K
- PSNL 1.1M
- Earning Date
- KIO 01-01-0001
- PSNL 08-05-2025
- Dividend Yield
- KIO 10.82%
- PSNL N/A
- EPS Growth
- KIO N/A
- PSNL N/A
- EPS
- KIO N/A
- PSNL N/A
- Revenue
- KIO N/A
- PSNL $80,317,000.00
- Revenue This Year
- KIO N/A
- PSNL $0.45
- Revenue Next Year
- KIO N/A
- PSNL $25.75
- P/E Ratio
- KIO N/A
- PSNL N/A
- Revenue Growth
- KIO N/A
- PSNL 0.36
- 52 Week Low
- KIO $10.52
- PSNL $2.83
- 52 Week High
- KIO $13.59
- PSNL $7.79
- Technical
- Relative Strength Index (RSI)
- KIO 44.51
- PSNL 42.30
- Support Level
- KIO $12.26
- PSNL $4.44
- Resistance Level
- KIO $12.70
- PSNL $5.03
- Average True Range (ATR)
- KIO 0.10
- PSNL 0.29
- MACD
- KIO -0.04
- PSNL 0.04
- Stochastic Oscillator
- KIO 38.60
- PSNL 79.83
About KIO KKR Income Opportunities Fund
KKR Income Opportunities Fund operates as a closed-end registered management investment company. It seeks to generate a high level of current income, with a secondary objective of capital appreciation. The company invests in the portfolio of loans and fixed-income instruments of U.S. and non-U.S. issuers. The company will invest at least 80% of its Managed Assets in loans and fixed-income instruments or other instruments, including derivative instruments, with similar economic characteristics under normal market conditions.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.